Immunotherapy for secondary glioblastoma multiforme: toward an isocitrate dehydrogenase vaccine

World Neurosurg. 2014 Dec;82(6):933-5. doi: 10.1016/j.wneu.2014.10.006. Epub 2014 Oct 13.

Authors

Isaac Josh Abecassis¹, Ryan P Morton¹, John D Nerva¹, Louis J Kim²

Affiliations

¹ Department of Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
² Department of Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA; Department of Radiology, University of Washington School of Medicine, Seattle, Washington, USA.

PMID: 25311977
DOI: 10.1016/j.wneu.2014.10.006

No abstract available

Publication types

News
Comment

MeSH terms

Animals
Cancer Vaccines / immunology*
Cancer Vaccines / therapeutic use*
Female
Glioma / immunology*
Glioma / therapy*
Humans
Isocitrate Dehydrogenase / genetics*
Isocitrate Dehydrogenase / immunology*
Male
Mutant Proteins / immunology*

Substances

Cancer Vaccines
Mutant Proteins
Isocitrate Dehydrogenase